Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Gross Profit (2020 - 2024)

LifeStance Health (LFST) has disclosed Gross Profit for 5 consecutive years, with $100.4 million as the latest value for Q3 2024.

  • On a quarterly basis, Gross Profit rose 31.78% to $100.4 million in Q3 2024 year-over-year; TTM through Sep 2024 was $376.3 million, a 33.68% increase, with the full-year FY2023 number at $302.1 million, up 27.46% from a year prior.
  • Gross Profit was $100.4 million for Q3 2024 at LifeStance Health, up from $97.8 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $241.2 million in Q4 2021 to a low of $14.2 million in Q2 2020.
  • A 5-year average of $76.0 million and a median of $66.1 million in 2022 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: skyrocketed 261.18% in 2021, then plummeted 74.01% in 2022.
  • LifeStance Health's Gross Profit stood at $33.1 million in 2020, then surged by 627.93% to $241.2 million in 2021, then tumbled by 74.01% to $62.7 million in 2022, then soared by 32.89% to $83.3 million in 2023, then increased by 20.55% to $100.4 million in 2024.
  • Per Business Quant, the three most recent readings for LFST's Gross Profit are $100.4 million (Q3 2024), $97.8 million (Q2 2024), and $94.7 million (Q1 2024).